PRINCETON, N.J., April 12 CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.
"We are pleased to launch our new logo and brand identity combined with a new comprehensive web site (http://www.corelabpartners.com) to the biopharmaceutical drug development sector," said CoreLab Partners' President and Chief Executive Officer, Mike Woehler. "As we continue our integration of the RadPharm and Medifacts functional teams, CoreLabs is creating a global business model which provides an innovative suite of imaging sciences solutions combined with a full spectrum of cardiac safety services; a powerful business proposition as our sponsors seek to streamline their vendor partners and establish long-term strategic relationships going forward," added Woehler.
Science. Service. Technology.
The CoreLab Partners' positioning includes the introduction of a new web site, distinct logo, new company tag line and refined mission statement designed to establish both a strong visual association with the company and effectively communicate a unique value proposition to the biopharmaceutical industry. CoreLab Partners' new brand identity is being launched to coincide with the Partnerships in Clinical Trials Conference in Orlando, Florida. Key company executives will be on hand at stands #515, 539 to meet with the sponsor community to answer any questions and discuss their expanded suite of service solutions.
About CoreLab Partners, Inc
CoreLab Partners, with offices in North America, Europe and Asia, provides complete medical image assessment services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with full-time, board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. CoreLab Partners also provides solutions for the collection, analysis and management of cardiac safety and efficacy information during drug development. Driven by best-in-class science, technology, and service quality, CoreLabs is a global leader providing ECG, Holter, Ambulatory Blood Pressure Monitoring, Spirometry, Glucometry, and Pulse Wave Analysis.
This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.
Contact: Kevin D. Duffy Vice President, Global Business Development Email: email@example.com Phone: 609-936-2600
SOURCE CoreLab Partners, Inc